Screener
AbbVie ABBV Short-Term Borrowings
Short-Term Borrowings at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:ShortTermBorrowings.
The source filing: AbbVie’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 8, 2026, 12:28 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001551152-26-000017
FAQ
- What is AbbVie's short-term borrowings?
- AbbVie (ABBV) reported short-term borrowings of $0 in Q1 2026.
- How has AbbVie's short-term borrowings changed year-over-year?
- AbbVie's short-term borrowings decreased by 100.0% year-over-year, from $1.59B to $0.
- What is the long-term trend for AbbVie's short-term borrowings?
- Over 5 years (2020 to 2025), AbbVie's short-term borrowings has grown at a 136.2% compound annual growth rate (CAGR), from $34M to $2.5B.
- What does short-term borrowings mean?
- Bank lines of credit, revolving credit facilities, and other short-term debt instruments with maturities under one year.
Ask your AI about AbbVie's short-term borrowings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude